AHSG and metabolic disease: Fetuin-A is known as an endogenous ligand that binds to free fatty acids and functions as an endogenous ligand for the Toll-like receptor TLR-4 thereby linking metabolic diseases (hyperlipidemia, insulin resistance) and subclinical inflammation [25].